Articles published by AnaptysBio, Inc.
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
August 05, 2024
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 11, 2024
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting
February 29, 2024
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Named a BioSpace 2024 Best Places to Work Winner
November 07, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update
November 02, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Participation in November Investor Conferences
November 01, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys to Present Phase 1 Data on ANB032, its BTLA Agonist Antibody, at the 32nd EADV Congress
October 11, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys to Provide Overview of Rosnilimab, a PD-1 Agonist, at Virtual R&D Event on Wednesday, Oct. 25
October 09, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
September 18, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio to Present at the Stifel 2023 Immunology and Inflammation Virtual Summit
September 12, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update
August 07, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 01, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio to Participate at the Cowen and Company 43rd Annual Health Care Conference
February 27, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio Announces Stock Repurchase Plan
January 13, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
January 05, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
Tickers
ANAB
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.